JP2008531479A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008531479A5 JP2008531479A5 JP2007553252A JP2007553252A JP2008531479A5 JP 2008531479 A5 JP2008531479 A5 JP 2008531479A5 JP 2007553252 A JP2007553252 A JP 2007553252A JP 2007553252 A JP2007553252 A JP 2007553252A JP 2008531479 A5 JP2008531479 A5 JP 2008531479A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- chloro
- amino
- group
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 22
- 239000002253 acid Substances 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 15
- -1 N-chloroaminoethylphosphonic acid diester Chemical class 0.000 claims description 12
- 150000002148 esters Chemical class 0.000 claims description 8
- VAUDXPRANUFYEC-UHFFFAOYSA-N 2-(chloroamino)-5-phosphonopentanoic acid Chemical compound OC(=O)C(NCl)CCCP(O)(O)=O VAUDXPRANUFYEC-UHFFFAOYSA-N 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims description 4
- DQSLXKNCNPPTSN-UHFFFAOYSA-N 1-(chloroamino)propylphosphonic acid Chemical compound CCC(NCl)P(O)(O)=O DQSLXKNCNPPTSN-UHFFFAOYSA-N 0.000 claims description 3
- XIGJZYVHLIRSFU-UHFFFAOYSA-N 2-(bromoamino)-5-phosphonopentanoic acid Chemical compound OC(=O)C(NBr)CCCP(O)(O)=O XIGJZYVHLIRSFU-UHFFFAOYSA-N 0.000 claims description 3
- KBINJLBTMJFAPH-UHFFFAOYSA-N 2-(chloroamino)-2-methylpropane-1-sulfonic acid Chemical compound ClNC(C)(C)CS(O)(=O)=O KBINJLBTMJFAPH-UHFFFAOYSA-N 0.000 claims description 3
- SCFWQPHRDQRQIW-UHFFFAOYSA-N 2-(chloroamino)-8-phosphonooctanoic acid Chemical compound OC(=O)C(NCl)CCCCCCP(O)(O)=O SCFWQPHRDQRQIW-UHFFFAOYSA-N 0.000 claims description 3
- BASCKKRUKJKATL-UHFFFAOYSA-N CC(C)C(NCl)P(O)(O)=O Chemical compound CC(C)C(NCl)P(O)(O)=O BASCKKRUKJKATL-UHFFFAOYSA-N 0.000 claims description 3
- DARKVQOMVNRQNZ-JEDNCBNOSA-N OBO.CC(C)C[C@H](NCl)C(O)=O Chemical compound OBO.CC(C)C[C@H](NCl)C(O)=O DARKVQOMVNRQNZ-JEDNCBNOSA-N 0.000 claims description 3
- 235000004279 alanine Nutrition 0.000 claims description 3
- BCRSJKZAODSYFK-UHFFFAOYSA-N 2-(chloroamino)-3-phosphonopropanoic acid Chemical compound OC(=O)C(NCl)CP(O)(O)=O BCRSJKZAODSYFK-UHFFFAOYSA-N 0.000 claims description 2
- IPWWLXWYFSGQFM-UHFFFAOYSA-N 2-(chloroamino)propane-1-sulfonic acid Chemical compound ClNC(C)CS(O)(=O)=O IPWWLXWYFSGQFM-UHFFFAOYSA-N 0.000 claims description 2
- GDVDLFHXJBBZOE-UHFFFAOYSA-N 3-(chloroamino)-2,2,3-trimethylbutanoic acid Chemical compound ClNC(C)(C)C(C)(C)C(O)=O GDVDLFHXJBBZOE-UHFFFAOYSA-N 0.000 claims description 2
- CEWZMYBSKUHYMS-UHFFFAOYSA-N 4-(chloroamino)-4-phosphonobutanoic acid Chemical compound OC(=O)CCC(NCl)P(O)(O)=O CEWZMYBSKUHYMS-UHFFFAOYSA-N 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 239000001257 hydrogen Substances 0.000 claims 10
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 150000002431 hydrogen Chemical class 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 5
- 239000004599 antimicrobial Substances 0.000 claims 4
- 150000001721 carbon Chemical group 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 229940121375 antifungal agent Drugs 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 244000052769 pathogen Species 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- 206010052428 Wound Diseases 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 2
- 239000003429 antifungal agent Substances 0.000 claims 2
- 229960005475 antiinfective agent Drugs 0.000 claims 2
- 239000003443 antiviral agent Substances 0.000 claims 2
- 239000003899 bactericide agent Substances 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 125000001589 carboacyl group Chemical group 0.000 claims 2
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical group C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 claims 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 125000002993 cycloalkylene group Chemical group 0.000 claims 2
- 238000005202 decontamination Methods 0.000 claims 2
- 230000003588 decontaminative effect Effects 0.000 claims 2
- 239000000645 desinfectant Substances 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000002346 iodo group Chemical group I* 0.000 claims 2
- 230000007774 longterm Effects 0.000 claims 2
- 230000003330 sporicidal effect Effects 0.000 claims 2
- 238000004659 sterilization and disinfection Methods 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 230000017423 tissue regeneration Effects 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 230000000843 anti-fungal effect Effects 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 230000012010 growth Effects 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 238000011069 regeneration method Methods 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
- QYNRGGHZWCUZLK-UHFFFAOYSA-N 2-(dichloroamino)-2-methylpropane-1-sulfonic acid Chemical compound ClN(Cl)C(C)(C)CS(O)(=O)=O QYNRGGHZWCUZLK-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- DRNNATGSBCVJBN-UHFFFAOYSA-N 2-amino-2-methylpropane-1-sulfonic acid Chemical compound CC(C)(N)CS(O)(=O)=O DRNNATGSBCVJBN-UHFFFAOYSA-N 0.000 description 5
- VOROEQBFPPIACJ-UHFFFAOYSA-N 5-Phosphononorvaline Chemical compound OC(=O)C(N)CCCP(O)(O)=O VOROEQBFPPIACJ-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 4
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- COIDHHVBAVTJFV-UHFFFAOYSA-N 2-(dichloroamino)-5-phosphonopentanoic acid Chemical compound OC(=O)C(N(Cl)Cl)CCCP(O)(O)=O COIDHHVBAVTJFV-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 229940000635 beta-alanine Drugs 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 2
- DGSLPJDIFKVSIB-UHFFFAOYSA-N (1-azaniumyl-2-methylpropyl)-hydroxyphosphinate Chemical compound CC(C)C(N)P(O)(O)=O DGSLPJDIFKVSIB-UHFFFAOYSA-N 0.000 description 2
- YIBKSASUZFBMOU-UHFFFAOYSA-N 1-(dichloroamino)propane-2-sulfonic acid Chemical compound OS(=O)(=O)C(C)CN(Cl)Cl YIBKSASUZFBMOU-UHFFFAOYSA-N 0.000 description 2
- DELJNDWGTWHHFA-UHFFFAOYSA-N 1-azaniumylpropyl(hydroxy)phosphinate Chemical compound CCC(N)P(O)(O)=O DELJNDWGTWHHFA-UHFFFAOYSA-N 0.000 description 2
- BAUYKXPDNLWGGL-UHFFFAOYSA-N 2-(chloroamino)propan-2-ylphosphonic acid Chemical compound ClNC(C)(C)P(O)(O)=O BAUYKXPDNLWGGL-UHFFFAOYSA-N 0.000 description 2
- JJQITYDTBUXIDS-UHFFFAOYSA-N 2-(dibromoamino)-2-methylpropane-1-sulfonic acid Chemical compound BrN(Br)C(C)(C)CS(O)(=O)=O JJQITYDTBUXIDS-UHFFFAOYSA-N 0.000 description 2
- IHEFYJCAHPMNNZ-UHFFFAOYSA-N 2-(dichloroamino)-8-phosphonooctanoic acid Chemical compound OC(=O)C(N(Cl)Cl)CCCCCCP(O)(O)=O IHEFYJCAHPMNNZ-UHFFFAOYSA-N 0.000 description 2
- LDSLVJUAHMPZBB-UHFFFAOYSA-N 2-(diiodoamino)ethanesulfonic acid Chemical compound OS(=O)(=O)CCN(I)I LDSLVJUAHMPZBB-UHFFFAOYSA-N 0.000 description 2
- XUGMGYUIGNYMJQ-UHFFFAOYSA-N 2-(iodoamino)ethanesulfonic acid Chemical compound OS(=O)(=O)CCNI XUGMGYUIGNYMJQ-UHFFFAOYSA-N 0.000 description 2
- IAZCXYBRDWVPNV-UHFFFAOYSA-N 2-amino-3-methyl-3-sulfobutanoic acid Chemical compound OS(=O)(=O)C(C)(C)C(N)C(O)=O IAZCXYBRDWVPNV-UHFFFAOYSA-N 0.000 description 2
- LBTABPSJONFLPO-UHFFFAOYSA-N 2-amino-3-phosphonopropanoic acid Chemical compound OC(=O)C(N)CP(O)(O)=O LBTABPSJONFLPO-UHFFFAOYSA-N 0.000 description 2
- DYGRPJWAYXRMQZ-UHFFFAOYSA-N 2-aminopropan-2-ylphosphonic acid Chemical compound CC(C)(N)P(O)(O)=O DYGRPJWAYXRMQZ-UHFFFAOYSA-N 0.000 description 2
- NETIXPOFUYPXNI-UHFFFAOYSA-N 2-aminopropane-2-sulfonic acid Chemical compound CC(C)(N)S(O)(=O)=O NETIXPOFUYPXNI-UHFFFAOYSA-N 0.000 description 2
- MWFMGBPGAXYFAR-UHFFFAOYSA-N 2-hydroxy-2-methylpropanenitrile Chemical compound CC(C)(O)C#N MWFMGBPGAXYFAR-UHFFFAOYSA-N 0.000 description 2
- OXIWSCWSIBBUDO-UHFFFAOYSA-N 3-(dichloroamino)-2,2,3-trimethylbutanoic acid Chemical compound ClN(Cl)C(C)(C)C(C)(C)C(O)=O OXIWSCWSIBBUDO-UHFFFAOYSA-N 0.000 description 2
- SNKZJIOFVMKAOJ-UHFFFAOYSA-N 3-Aminopropanesulfonate Chemical compound NCCCS(O)(=O)=O SNKZJIOFVMKAOJ-UHFFFAOYSA-N 0.000 description 2
- DWYLYZGWBIVRGV-UHFFFAOYSA-N 4-(dichloroamino)-4-phosphonobutanoic acid Chemical compound OC(=O)CCC(N(Cl)Cl)P(O)(O)=O DWYLYZGWBIVRGV-UHFFFAOYSA-N 0.000 description 2
- SODXFOVXZATGPJ-UHFFFAOYSA-N 4-amino-4-phosphonobutanoic acid Chemical compound OP(=O)(O)C(N)CCC(O)=O SODXFOVXZATGPJ-UHFFFAOYSA-N 0.000 description 2
- OPIXQPCOZBIRMY-UHFFFAOYSA-N CC(C)CC(N)(C(O)=O)P(O)(O)=O Chemical compound CC(C)CC(N)(C(O)=O)P(O)(O)=O OPIXQPCOZBIRMY-UHFFFAOYSA-N 0.000 description 2
- 241001135569 Human adenovirus 5 Species 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- YKTCVYHHAFHLHL-JEDNCBNOSA-N OBO.CC(C)C[C@H](N(Cl)Cl)C(O)=O Chemical compound OBO.CC(C)C[C@H](N(Cl)Cl)C(O)=O YKTCVYHHAFHLHL-JEDNCBNOSA-N 0.000 description 2
- KXCDENIMXRKIPT-UHFFFAOYSA-N OBO.OC(=O)CCNCl Chemical compound OBO.OC(=O)CCNCl KXCDENIMXRKIPT-UHFFFAOYSA-N 0.000 description 2
- GBUDGXDEROGHBY-JEDNCBNOSA-N OP(O)=O.CC(C)C[C@H](N(Cl)Cl)C(O)=O Chemical compound OP(O)=O.CC(C)C[C@H](N(Cl)Cl)C(O)=O GBUDGXDEROGHBY-JEDNCBNOSA-N 0.000 description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 2
- LDCBEAIUZPYSBX-JEDNCBNOSA-N P(O)(O)=O.ClN[C@@H](CC(C)C)C(=O)O Chemical compound P(O)(O)=O.ClN[C@@H](CC(C)C)C(=O)O LDCBEAIUZPYSBX-JEDNCBNOSA-N 0.000 description 2
- UEQTVRUQHVQHSW-UHFFFAOYSA-N [1-(dichloroamino)-2-methylpropyl]phosphonic acid Chemical compound CC(C)C(N(Cl)Cl)P(O)(O)=O UEQTVRUQHVQHSW-UHFFFAOYSA-N 0.000 description 2
- YDONNITUKPKTIG-UHFFFAOYSA-N [Nitrilotris(methylene)]trisphosphonic acid Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CP(O)(O)=O YDONNITUKPKTIG-UHFFFAOYSA-N 0.000 description 2
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 239000013580 millipore water Substances 0.000 description 2
- 229960003104 ornithine Drugs 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- MEGHVKHOSRPKFB-REOHCLBHSA-N (2s)-2-(dichloroamino)propanoic acid Chemical compound ClN(Cl)[C@@H](C)C(O)=O MEGHVKHOSRPKFB-REOHCLBHSA-N 0.000 description 1
- QUOIXMXPWCACSF-UHFFFAOYSA-N 1-(dichloroamino)propylphosphonic acid Chemical compound CCC(N(Cl)Cl)P(O)(O)=O QUOIXMXPWCACSF-UHFFFAOYSA-N 0.000 description 1
- ZFJWYAYBWZHPGT-UHFFFAOYSA-N 1-amino-2-methylpropane-2-sulfonic acid Chemical compound NCC(C)(C)S(O)(=O)=O ZFJWYAYBWZHPGT-UHFFFAOYSA-N 0.000 description 1
- GBYFFQSMDBOMCX-UHFFFAOYSA-N 2-(dibromoamino)-5-phosphonopentanoic acid Chemical compound OC(=O)C(N(Br)Br)CCCP(O)(O)=O GBYFFQSMDBOMCX-UHFFFAOYSA-N 0.000 description 1
- YDRDBSJEDQYEFJ-UHFFFAOYSA-N 2-(dichloroamino)-3-phosphonopropanoic acid Chemical compound OC(=O)C(N(Cl)Cl)CP(O)(O)=O YDRDBSJEDQYEFJ-UHFFFAOYSA-N 0.000 description 1
- FWACYDHVHFBQHS-UHFFFAOYSA-N 2-(dichloroamino)propan-2-ylphosphonic acid Chemical compound ClN(Cl)C(C)(C)P(O)(O)=O FWACYDHVHFBQHS-UHFFFAOYSA-N 0.000 description 1
- WYRXPDKKQWTPKX-UHFFFAOYSA-N 2-(dichloroamino)propane-1-sulfonic acid Chemical compound ClN(Cl)C(C)CS(O)(=O)=O WYRXPDKKQWTPKX-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- KGGCRFYWXLVUQQ-UHFFFAOYSA-N 2-amino-8-phosphonooctanoic acid Chemical compound OC(=O)C(N)CCCCCCP(O)(O)=O KGGCRFYWXLVUQQ-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 229910019093 NaOCl Inorganic materials 0.000 description 1
- YFXICVBBMRYJMK-UHFFFAOYSA-N OBO.NCCC(O)=O Chemical compound OBO.NCCC(O)=O YFXICVBBMRYJMK-UHFFFAOYSA-N 0.000 description 1
- DXDZUCBULNMIIX-UHFFFAOYSA-N OBO.OC(=O)CCN(Cl)Cl Chemical compound OBO.OC(=O)CCN(Cl)Cl DXDZUCBULNMIIX-UHFFFAOYSA-N 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- BMGMQYRPZOGZFU-YFKPBYRVSA-N [(1r)-1-amino-3-methylbutyl]boronic acid Chemical compound CC(C)C[C@H](N)B(O)O BMGMQYRPZOGZFU-YFKPBYRVSA-N 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical class C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 description 1
- 229960000308 fosfomycin Drugs 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000003328 mesylation reaction Methods 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64736605P | 2005-01-25 | 2005-01-25 | |
| US60/647,366 | 2005-01-25 | ||
| PCT/US2006/002875 WO2006081392A1 (en) | 2005-01-25 | 2006-01-25 | N-halogenated amino acids and n, n-dihalogenated amino acids in combination with hypohalous acids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008531479A JP2008531479A (ja) | 2008-08-14 |
| JP2008531479A5 true JP2008531479A5 (cg-RX-API-DMAC7.html) | 2009-03-05 |
| JP5329095B2 JP5329095B2 (ja) | 2013-10-30 |
Family
ID=36441417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007553252A Expired - Fee Related JP5329095B2 (ja) | 2005-01-25 | 2006-01-25 | 次亜ハロゲン酸と組み合わせる、ｎ−ハロゲン化アミノ酸およびｎ，ｎ−ジハロゲン化アミノ酸 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7846971B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1896001B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5329095B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20070098947A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101132785A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006208046B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0607302A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2595889C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2421157T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL184771A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007008928A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI386201B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006081392A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200706402B (cg-RX-API-DMAC7.html) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1656095T3 (en) * | 2003-08-18 | 2014-03-10 | Novabay Pharmaceuticals Inc | N, N-DIHALOGENG-GENERATED AMINO ACIDS AND DERIVATIVES |
| US8747882B2 (en) | 2005-04-21 | 2014-06-10 | Astra Tech Ab | Catheter assembly with bactericidal effect |
| US20090221989A1 (en) * | 2005-09-21 | 2009-09-03 | Novabay Pharmaceuticals Inc | System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid composition |
| JP2009511493A (ja) * | 2005-10-06 | 2009-03-19 | ノバベイ・ファーマシューティカルズ・インコーポレイテッド | Ｎ−ハロゲン化アミノ酸を使用する、尿路感染症（ｕｔｉ）を含む細菌感染症および真菌感染症の予防のためのシステムおよび方法 |
| TW200843787A (en) * | 2006-12-29 | 2008-11-16 | Novabay Pharmaceuticals Inc | N-halogenated amino compounds and derivatives; compositions and methods of using them |
| EP2111252A4 (en) * | 2007-01-31 | 2010-12-01 | Adam Heller | MANAGEMENT OF PAIN BY ELECTROCHEMICAL PATHWAY |
| UY31057A1 (es) * | 2007-05-01 | 2008-10-31 | Alcon Res Ltd | Formulaciones de aminoacido n-halogenado que contiene acido alifatico |
| UY31058A1 (es) * | 2007-05-01 | 2008-10-31 | Alcon Res Ltd | Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios |
| UY31056A1 (es) * | 2007-05-01 | 2008-10-31 | Alcon Res Ltd | Fromulaciones aminocido n-halogenado y metodos de limpieza y desinfeccion |
| UY31059A1 (es) * | 2007-05-01 | 2008-10-31 | Alcon Res Ltd | Formulaciones de aminoacido n-halogenado |
| UY31055A1 (es) * | 2008-02-01 | 2008-10-31 | Alcon Res Ltd | Sales antimicrobianas de aminoacido n-halogenado |
| JP2011516578A (ja) * | 2008-04-10 | 2011-05-26 | ノバベイ・ファーマシューティカルズ・インコーポレイテッド | 気管支肺感染症の治療および予防のための組成物および方法 |
| CA2723262A1 (en) * | 2008-04-15 | 2009-10-22 | Waldemar Gottardi | Compositions and devices for antisepsis and anticoagulation |
| IL192262A (en) * | 2008-06-17 | 2016-05-31 | Z H T Eng Equipment And Tech Ltd | A polymer that releases drugs into the animal body, a medicinal product containing it and a method for its preparation |
| WO2010017405A1 (en) * | 2008-08-06 | 2010-02-11 | Adam Heller | Methods and compositions for the treatment of pain |
| US20100076089A1 (en) * | 2008-08-12 | 2010-03-25 | Novabay Pharmaceuticals, Inc. | Antimicrobial gel formulations |
| WO2010044862A1 (en) | 2008-10-17 | 2010-04-22 | Ai Medical Devices, Inc. | Endotracheal intubation device |
| CA2741667A1 (en) | 2008-11-07 | 2010-05-14 | Novabay Pharmaceuticals, Inc. | Antimicrobial n-chlorinated compositions |
| WO2010054009A1 (en) * | 2008-11-07 | 2010-05-14 | Novabay Pharmaceuticals, Inc. | Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions |
| WO2010091280A1 (en) | 2009-02-06 | 2010-08-12 | Alcon Research, Ltd. | N-halogenated amino acid formulations comprising phosphine or amine oxides |
| RU2520034C2 (ru) * | 2009-03-18 | 2014-06-20 | ОЛАТЕК ИНДАСТРИЗ ЭлЭлСи | Соединения для лечения воспаления |
| US20100272783A1 (en) * | 2009-04-24 | 2010-10-28 | Novabay Pharmaceuticals, Inc. | Methods of Treating Infections of the Nail |
| US20110020474A1 (en) * | 2009-07-27 | 2011-01-27 | Novabay Pharmaceuticals, Inc. | Methods of Treating Infections of the Nail or Skin Using Hypohalite |
| EP2531026A4 (en) * | 2010-02-04 | 2013-09-25 | Novabay Pharmaceuticals Inc | ANTIMICROBIAL FORMULATIONS ON POLYSACCHARID BASE |
| US9888832B2 (en) | 2010-09-24 | 2018-02-13 | Blink Device LLC | Endotracheal intubation device |
| TWI407907B (zh) | 2010-10-04 | 2013-09-11 | Far Eastern New Century Corp | An antibacterial agent with water solubility and biodegradability |
| JP5952899B2 (ja) | 2011-06-15 | 2016-07-13 | アルエルエス グローバル アーベー | う蝕象牙質組織の検出と除去 |
| SE536581C2 (sv) | 2012-07-24 | 2014-03-11 | Rls Global Ab | Ett kit för behandling av sår eller liknande och ett preparat och metoder därav |
| US11814739B2 (en) | 2016-06-09 | 2023-11-14 | De Nora Holdings Us, Inc. | Electrolytic production of organic chloramine solutions |
| EP3745861A1 (en) * | 2018-01-30 | 2020-12-09 | Buckman Laboratories International, Inc. | Synergistic combinations of monochloramine and organic acid, and methods of using the same for microbial control |
| CN113729039A (zh) * | 2021-08-27 | 2021-12-03 | 上海罗克环控节能科技股份有限公司 | 一种绿色环保消毒液及其制造方法 |
| US12251486B2 (en) | 2021-09-09 | 2025-03-18 | Toyota Motor North America, Inc. | Vehicle sanitizing systems and methods for using the same |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3998945A (en) * | 1972-06-12 | 1976-12-21 | National Patent Development Corporation | Dental treatment |
| US3950536A (en) | 1974-02-01 | 1976-04-13 | Sol Joseph Barer | N,N-Dichloro substituted aminocarboxylic acids as bactericides and fungicides |
| US4015008A (en) | 1974-02-01 | 1977-03-29 | National Patent Development Corporation | N,N-dichloro substituted aminocarboxylic acids as microbiocides |
| US3966796A (en) | 1974-06-14 | 1976-06-29 | Interx Research Corporation | N-chloro-amino acid derivatives activity |
| US4045578A (en) | 1974-06-14 | 1977-08-30 | Interx Research Corporation | N-chloro-amino acid derivatives exhibiting antibacterial activity |
| US4386103A (en) | 1981-01-30 | 1983-05-31 | Merck & Co., Inc. | Dichloroamino acid derivatives useful as potent germicidal and fungicidal agents |
| US5096700A (en) | 1990-09-28 | 1992-03-17 | The Procter & Gamble Company | Halogenated aminohexanoates and aminobutyrates antimicrobial agents |
| DE4041703C2 (de) | 1990-12-24 | 1993-10-21 | Waldemar Dr Gottardi | Alkalimetallsalze des N-Chlortaurins in kristalliner Form, Verfahren zu deren Herstellung und deren Verwendung |
| JP3759757B2 (ja) * | 1994-01-13 | 2006-03-29 | 相互薬工株式会社 | 殺菌剤 |
| US5753701A (en) | 1996-10-25 | 1998-05-19 | University Of Kentucky | N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters as novel safe agents for water disinfection |
| DE19712565A1 (de) * | 1997-03-25 | 1998-10-01 | Thomas W Dr Stief | Arzneimittel auf der Basis eines Singulett-Sauerstoff erzeugenden Agenzes |
| DE19816102C1 (de) * | 1998-04-10 | 1999-09-16 | Waldemar Gottardi | Verfahren zum Inaktivieren von Viren in Proteinlösungen, Verwendung von N-Chlortaurin in dem Verfahren sowie nach dem Verfahren hergestellte Proteinlösungen |
| CA2320556A1 (en) | 1999-09-29 | 2001-03-29 | Queen's University At Kingston | N,n-dichlorinated omega amino acids and uses thereof |
| AU2001285944A1 (en) | 2000-09-14 | 2002-03-26 | Waldemar Gottardi | Fungicidal agent containing n-chlorotaurine and use thereof |
| FR2819723B1 (fr) * | 2001-01-23 | 2006-11-17 | Arnaud Mainnemare | Composition halogene, son procede de preparation et ses utilisations |
| WO2004003702A2 (en) * | 2002-06-27 | 2004-01-08 | Geranio Nicholas L | Integrated property database and search engine |
| DK1656095T3 (en) | 2003-08-18 | 2014-03-10 | Novabay Pharmaceuticals Inc | N, N-DIHALOGENG-GENERATED AMINO ACIDS AND DERIVATIVES |
| EP1713785A1 (en) | 2003-12-17 | 2006-10-25 | Rib-X Pharmaceuticals, Inc. | Halogenated biaryl heterocyclic compounds and methods of making and using the same |
| TW200843787A (en) | 2006-12-29 | 2008-11-16 | Novabay Pharmaceuticals Inc | N-halogenated amino compounds and derivatives; compositions and methods of using them |
-
2006
- 2006-01-24 TW TW095102567A patent/TWI386201B/zh not_active IP Right Cessation
- 2006-01-25 CN CNA2006800070563A patent/CN101132785A/zh active Pending
- 2006-01-25 KR KR1020077019438A patent/KR20070098947A/ko not_active Ceased
- 2006-01-25 EP EP06733945.7A patent/EP1896001B1/en not_active Not-in-force
- 2006-01-25 ES ES06733945T patent/ES2421157T3/es active Active
- 2006-01-25 MX MX2007008928A patent/MX2007008928A/es active IP Right Grant
- 2006-01-25 US US11/339,987 patent/US7846971B2/en active Active
- 2006-01-25 AU AU2006208046A patent/AU2006208046B2/en not_active Ceased
- 2006-01-25 JP JP2007553252A patent/JP5329095B2/ja not_active Expired - Fee Related
- 2006-01-25 WO PCT/US2006/002875 patent/WO2006081392A1/en not_active Ceased
- 2006-01-25 CA CA2595889A patent/CA2595889C/en not_active Expired - Fee Related
- 2006-01-25 BR BRPI0607302-6A patent/BRPI0607302A2/pt not_active Application Discontinuation
-
2007
- 2007-07-23 IL IL184771A patent/IL184771A/en active IP Right Grant
- 2007-08-01 ZA ZA2007/06402A patent/ZA200706402B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008531479A5 (cg-RX-API-DMAC7.html) | ||
| CA2595889C (en) | N-halogenated amino acids and n,n-dihalogenated amino acids in combination with hypohalous acids | |
| US7893109B2 (en) | N,N-dihalogenated amino acids and derivatives | |
| JP5564264B2 (ja) | Ｎ−ハロゲン化アミノ化合物および誘導体 | |
| CY1115940T1 (el) | Παραγωγα υποκατεστημενου φαινυλαλκανοϊκου οξεος και η χρηση τους για τη θεραπευτικη αντιμετωπιση αναπνευστικων ασθενειων | |
| CN105407729A (zh) | 包含聚胺的组合物和方法 | |
| Xin et al. | Oral environment-adaptive peptide–polymer conjugate for caries prevention with targeting, antibacterial, and antifouling abilities | |
| WO2021066080A1 (ja) | 薬剤、薬剤の製造方法、および、水の浄化方法 | |
| BRPI0407368A (pt) | tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas. | |
| JP2010526082A5 (cg-RX-API-DMAC7.html) | ||
| JP6269946B2 (ja) | 細菌の増殖抑制 | |
| RU2008128350A (ru) | Производные дифенилмочевины | |
| HK1117748A (en) | N-halogenated amino acids and n, n-dihalogenated amino acids in combination with hypohalous acids | |
| HK1103713B (en) | N,n-dihalogenated amino acids and derivatives |